3d
Zacks.com on MSNTempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip?Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...
A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...
Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...
Tempus AI Inc (TEM) reports impressive revenue growth, strategic acquisitions, and extended partnerships, setting the stage for a promising 2025.
Tempus posted a fourth-quarter adjusted net loss of $0.18 per share, $0.02 more per share than estimates by analysts surveyed ...
Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results